Trial intelligence / Profile preview

Remifentanil vs Sevoflurane in Valvular Heart Surgery

NCT02400879Completed

Sponsor
Konkuk University Medical Center
Start
Oct 2015
Primary completion
Oct 2015
Modality
Orthosteric Ligands
01

Overview

Randomised, single-blind trial of remifentanil in valvular heart disease (VHD), sponsored by Konkuk University Medical Center. Started Oct 2015; status: completed.

02

Drugs

remifentanil
03

Conditions

valvular heart disease (VHD)

Beyond the preview

Go deeper on NCT02400879.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02400879.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call